Not applicableUnknownNCT04253327What this trial is testingDistress, Anxiety and Psychosexual Health in BOTWho this might be right forOvarian Neoplasm Epithelial Borderline Universitair Ziekenhuis Brussel 60
Early research (Phase 1)Study completedNCT00014456What this trial is testingCombination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid TumorsWho this might be right forBladder CancerBreast CancerCarcinoma of Unknown Primary+9 more Dartmouth-Hitchcock Medical Center 35
Early research (Phase 1)Study completedNCT00004065What this trial is testingChemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerWho this might be right forBladder CancerBreast CancerColorectal Cancer+9 more Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT05500391What this trial is testingAssessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote MonitoringWho this might be right forStage I Testicular SeminomaStage I Testicular Nonseminomatous Germ Cell TumorGastrointestinal Stromal Tumors+11 more Centre Oscar Lambret 88
Not applicableStudy completedNCT00003763What this trial is testingRadiolabeled Folic Acid and Imaging to Detect Ovarian CancerWho this might be right forOvarian Cancer Endocyte 35
Not applicableUnknownNCT02408536What this trial is testingObservational Retrospective Study on Treatment and Outcomes in Patients With Low-grade Serous Ovarian CancerWho this might be right forLow-grade Serous Ovarian CarcinomaRecurrent Invasive Borderline Serous Ovarian Cancer National Cancer Institute, Naples 150
Not applicableActive Not RecruitingNCT06709872What this trial is testingA Prospective Multicenter Diagnostic Biomarker Study to Discriminate Borderline from Stage I Invasive Ovarian CancerWho this might be right forStage I Ovarian CancerBorderline Ovarian Tumors KU Leuven 400
Early research (Phase 1)Study completedNCT00006981What this trial is testingImmunotoxin Therapy in Treating Patients With Advanced CancerWho this might be right forCervical CancerFallopian Tube CancerHead and Neck Cancer+5 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00049556What this trial is testingGefitinib in Treating Patients With Cervical CancerWho this might be right forCervical CancerFallopian Tube CancerOvarian Cancer+1 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00003103What this trial is testingChemotherapy in Treating Patients With Solid TumorsWho this might be right forBladder CancerBreast CancerColorectal Cancer+7 more Memorial Sloan Kettering Cancer Center 57
Large-scale testing (Phase 3)Active Not RecruitingNCT01081262What this trial is testingCarboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube CancerWho this might be right forBorderline Ovarian Mucinous TumorOvarian Mucinous CystadenocarcinomaRecurrent Fallopian Tube Carcinoma+21 more National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Ended earlyNCT00505661What this trial is testingLetrozole in Patients With Ovarian TumorsWho this might be right forOvarian CancerFallopian Tube CancerPeritoneal Cancer M.D. Anderson Cancer Center 16
Not applicableStudy completedNCT06825468What this trial is testingRole of Hysterectomy in the Treatment of Borderline Ovarian TumorsWho this might be right forHysterectomy IRCCS Azienda Ospedaliero-Universitaria di Bologna 168
Early research (Phase 1)Study completedNCT02520115What this trial is testingFolate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian CancerWho this might be right forAdnexal MassBorderline Ovarian Epithelial TumorOvarian Clear Cell Tumor+4 more Barbara Ann Karmanos Cancer Institute 50
Testing effectiveness (Phase 2)UnknownNCT00021385What this trial is testingSqualamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian CancerWho this might be right forOvarian Cancer Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00031681What this trial is testing7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)Who this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more National Cancer Institute (NCI) 41
Early research (Phase 1)Study completedNCT00003704What this trial is testingChemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal CancerWho this might be right forCancer Alliance for Clinical Trials in Oncology 51
Testing effectiveness (Phase 2)Study completedNCT00381888What this trial is testingFondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic CancerWho this might be right forCervical CancerEndometrial CancerFallopian Tube Cancer+5 more Masonic Cancer Center, University of Minnesota 44
Testing effectiveness (Phase 2)Study completedNCT00301756What this trial is testingBelinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential TumorsWho this might be right forFallopian Tube CarcinomaPrimary Peritoneal CarcinomaRecurrent Borderline Ovarian Surface Epithelial-Stromal Tumor+5 more National Cancer Institute (NCI) 32
Early research (Phase 1)Study completedNCT00006036What this trial is testingLiposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid TumorsWho this might be right forHead and Neck CancerLung CancerOvarian Cancer+1 more NCIC Clinical Trials Group 14